These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 9839740)

  • 61. [Assessment of efficacy and safety of medical treatment of non-viable first trimester pregnancy].
    Zwierzchowska A; Głuszak M; Jabiry-Zieniewicz Z; Banaszek-Wysoczańska A; Dziadecki W; Barcz E
    Ginekol Pol; 2012 Oct; 83(10):760-5. PubMed ID: 23383562
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Dilatation and evacuation procedures and second-trimester abortions. The role of physician skill and hospital setting.
    Cates W; Schulz KF; Grimes DA; Horowitz AJ; Lyon FA; Kravitz FH; Frisch MJ
    JAMA; 1982 Aug; 248(5):559-63. PubMed ID: 6285012
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Induction of abortion with mifepristone (RU 486) and oral or vaginal misoprostol.
    el-Refaey H; Rajasekar D; Abdalla M; Calder L; Templeton A
    N Engl J Med; 1995 Apr; 332(15):983-7. PubMed ID: 7885426
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Women's perceptions of and experiences with the use of misoprostol for treatment of incomplete abortion in central Malawi: a mixed methods study.
    Chakhame BM; Darj E; Mwapasa M; Kafulafula UK; Maluwa A; Odland JØ; Odland ML
    Reprod Health; 2023 Feb; 20(1):26. PubMed ID: 36732793
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Misoprostol: pathways, mediation and social networks for access to abortion using medication in the context of illegality in the State of Sao Paulo].
    Arilha MM
    Cien Saude Colet; 2012 Jul; 17(7):1785-94. PubMed ID: 22872340
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Hospital admission following induced abortion in Eastern Highlands Province, Papua New Guinea--a descriptive study.
    Vallely LM; Homiehombo P; Kelly-Hanku A; Kumbia A; Mola GD; Whittaker A
    PLoS One; 2014; 9(10):e110791. PubMed ID: 25329982
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [The efficacy and acceptability of mifepristone medical abortion with home administration misoprostol provided by private providers linked with the hospital: a prospective study of 433 patients].
    Faucher P; Baunot N; Madelenat P
    Gynecol Obstet Fertil; 2005 Apr; 33(4):220-7. PubMed ID: 15894206
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The risk of unwanted pregnancy, a Latin American perspective.
    Viel B
    IPPF Med Bull; 1989 Feb; 23(1):1-3. PubMed ID: 12281958
    [TBL] [Abstract][Full Text] [Related]  

  • 69. An Overview of Unsafe Abortion: Patterns and Outcomes in a Tertiary Level Hospital.
    Shamsi S; Mirza TT; Shejuti TR; Nigar K; Nahar S; Begum S; Sharmin T; Panna LK; Islam N; Jahan T
    Mymensingh Med J; 2020 Jul; 29(3):523-529. PubMed ID: 32844789
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Unsafe abortion in Kenya: a cross-sectional study of abortion complication severity and associated factors.
    Ziraba AK; Izugbara C; Levandowski BA; Gebreselassie H; Mutua M; Mohamed SF; Egesa C; Kimani-Murage EW
    BMC Pregnancy Childbirth; 2015 Feb; 15():34. PubMed ID: 25884662
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Abortion: a public health or a family planning problem].
    Aguayo Hernandez JR
    Emisor Demogr; 1991; 5(1):19-24. PubMed ID: 12317070
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Early termination of pregnancy with mifepristone (RU 486) and the orally active prostaglandin misoprostol.
    Peyron R; Aubény E; Targosz V; Silvestre L; Renault M; Elkik F; Leclerc P; Ulmann A; Baulieu EE
    N Engl J Med; 1993 May; 328(21):1509-13. PubMed ID: 8479487
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The need for reform.
    Viel B
    Plan Parent Chall; 1993; (1):12-3. PubMed ID: 12345316
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Oral misoprostol versus placebo for cervical dilatation before vacuum aspiration in first trimester pregnancy.
    Ngai SW; Tang OS; Lao T; Ho PC; Ma HK
    Hum Reprod; 1995 May; 10(5):1220-2. PubMed ID: 7657769
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Reaching women with instructions on misoprostol use in a Latin American country.
    Cohen J; Ortiz O; Llaguno SE; Goodyear L; Billings D; Martinez I
    Reprod Health Matters; 2005 Nov; 13(26):84-92. PubMed ID: 16291489
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Trends in misoprostol use and abortion complications: A cross-sectional study from nine referral hospitals in Nigeria.
    Bello FA; Fawole B; Oluborode B; Awowole I; Irinyenikan T; Awonuga D; Loto O; Fabamwo A; Guest P; Ganatra B
    PLoS One; 2018; 13(12):e0209415. PubMed ID: 30596683
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Maternal mortality and morbidity of unsafe abortion in a university teaching hospital of Karachi, Pakistan.
    Shah N; Hossain N; Noonari M; Khan NH
    J Pak Med Assoc; 2011 Jun; 61(6):582-6. PubMed ID: 22204215
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Abortion policy and women's health in developing countries.
    Dixon-Mueller R
    Int J Health Serv; 1990; 20(2):297-314. PubMed ID: 2332264
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Complications of first-trimester abortion by vacuum aspiration after cervical preparation with and without misoprostol: a multicentre randomised trial.
    Meirik O; My Huong NT; Piaggio G; Bergel E; von Hertzen H;
    Lancet; 2012 May; 379(9828):1817-24. PubMed ID: 22405255
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Backstreet abortion: women's experiences.
    Maforah F; Wood K; Jewkes R
    Curationis; 1997 Jul; 20(2):79-82. PubMed ID: 9418421
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.